Skip to content
Open access

A tRNA-derived second messenger mediates antiviral defense

Aug 2026 · bioRxiv · 0 citations · 45 references
Biology

TL;DR

A CRISPR-associated kinase (CASK) system that links the recognition of target RNA to protein phosphorylation to establish CASK systems as a new platform for RNA sensing and for engineering programmable phosphorylation-based signaling systems.

Abstract

CRISPR-Cas systems are RNA-guided nucleases that enable prokaryotic immunity; however, some loci encode additional associated genes that cooperate with CRISPR effectors to perform diverse biological functions. Here, we uncover a CRISPR-associated kinase (CASK) system that links the recognition of target RNA to protein phosphorylation. We show that the kinase Csx33 phosphorylates Csx34 following activation of Cas13, enabling Csx34 to bind DNA in a sequence- specific manner. Together, Csx33 and Csx34 function as a transcriptional activation module that upregulates cas13 and associated genes, revealing a positive autoregulatory circuit that potentiates the immune response upon detection of foreign RNA. At the molecular level, Csx33 is activated by CCA trinucleotide RNA generated by Cas13-mediated cleavage of tRNA 3′ tails, uncovering a novel linear second messenger in bacterial immunity and a previously unrecognized signaling role of collateral RNA fragments. Together, these findings establish CASK systems as a new platform for RNA sensing and for engineering programmable phosphorylation-based signaling systems.

Read PDF

Similar papers

Open access Oct 2026

tRNA-derived second messengers confer bacterial immunity

A nuclease-driven immune signaling pathway in which tRNA cleavage generates a specific small molecule that triggers cell death in response to RNA-guided transcript recognition in prokaryotes is reported.

L. Valentin-Alvarado, Peter H. Yoon, Santiago C. Lopez et al. · 0 citations
Open access Oct 2026

Csx15 is a broad specificity ring nuclease bridging CRISPR-Cas and CBASS cyclic nucleotide signaling systems

Prokaryotic antiviral type III CRISPR-Cas and CBASS systems use cyclic nucleotides as second messengers to activate diverse effector proteins. Whereas CBASS signaling typically triggers abortive infection, type III CRISPR-Cas signaling is tightly regulated through controlled signal production and degradation. Here, we...

D. Klimavicius, Dominik Rafalski, Dalia Smalakytė et al. · 0 citations
Open access Sep 2026

A Noncontiguous Code for RNA-Guided DNA Recognition at the Origin of CRISPR-Cas

The discovery of Viral Interference Programmable Repeat systems consisting of a Vipr protein ancestral to the earliest CRISPR-Cas effectors and VIPR RNAs (vrRNAs) comprising alternating GGY/NN motifs suggests that adaptive immunity originated from ancient warfare between viruses.

Peter H. Yoon, Kenneth J. Loi, Z. Zhang et al. · 3 citations
Open access Oct 2026

Aminoacylated tRNA tails trigger auxiliary bacterial immunity

It is reported that aminoacylated tRNA tails cleaved during an immune response in bacteria serve as diffusible signals that trigger auxiliary immunity and establish aminoacylated tRNA fragments as cellular signaling molecules.

Yan Yan, Balwina Koopal, Sobita Kunwar et al. · 0 citations
Open access Sep 2026

BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA

Abstract The CRISPR–Cas12 family encompasses diverse RNA-guided nucleases with both DNA- and RNA-targeting subtypes. They can trigger antiviral activities through either direct elimination of invading nucleic acids or activating broad collateral cleavage to induce abortive infection. Here, we report a novel type V CRIS...

Xin Li, Chen-Wei Wu, Jin-Shan Guo et al. · 0 citations
Open access Sep 2026

Split Activator Assembly via Aptamer Binding Enables CRISPR-Cas12a Activation with Non-Nucleic Acid Targets

The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and...

R. J. Tharu, Yusha Imtiaz, Shubhajit Singha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.